Ignite Creation Date:
2025-12-24 @ 5:31 PM
Ignite Modification Date:
2025-12-24 @ 5:31 PM
Study NCT ID:
NCT04173468
Status:
COMPLETED
Last Update Posted:
2020-01-18
First Post:
2019-11-20
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Mobilization With Movement Versus Mulligan Knee Taping Technique on Patellofemoral Pain Syndrome.
Sponsor:
Riphah International University
Organization:
Study Overview
Official Title:
Comparison of Mobilization With Movement and Mulligan Knee Taping Technique on Patellofemoral Pain Syndrome.
Status:
COMPLETED
Status Verified Date:
2020-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study intends to determine the effects of MWM verses Mulligan knee taping on patellofemoral pain syndrome.
Detailed Description:
This is a single blinded randomized controlled trial, will be conducted at Pakistan railway general hospital Rawalpindi. Both MWM and Mulligan knee taping Techniques are used in patients with patellofemoral pain syndrome. Sample size of 34 individuals was calculated through Open Epi tool version 3 with 95 % confidence interval (CI), and power 80%. 34 individuals were screened out on the basis of inclusion and exclusion criteria. Individuals of this selected population were randomly allocated as 17 individuals in MWM (straight leg raise with traction and tibial gliding) group and 17 individuals Mulligan knee taping group by sealed envelope method. And after this Both groups will receive conventional therapy.
Assesment will be done at baseline, 2nd week and after 6 weeks Data will be analyzed on SPSS version 21.
Assesment will be done at baseline, 2nd week and after 6 weeks Data will be analyzed on SPSS version 21.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: